These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 14696996)

  • 21. Perceptual evaluation of motor speech following treatment for childhood cerebellar tumour.
    Cornwell PL; Murdoch BE; Ward EC; Kellie S
    Clin Linguist Phon; 2003 Dec; 17(8):597-615. PubMed ID: 14977025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved status following behavioural intervention in a case of severe dysarthria with stroke aetiology.
    Mackenzie C; Lowit A
    Int J Speech Lang Pathol; 2012 Aug; 14(4):318-28. PubMed ID: 22348261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aided and unaided speech supplementation strategies: effect of alphabet cues and iconic hand gestures on dysarthric speech.
    Hustad KC; Garcia JM
    J Speech Lang Hear Res; 2005 Oct; 48(5):996-1012. PubMed ID: 16411790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Orofacial myofunctional therapy in dysarthria: a study on speech intelligibility.
    Ray J
    Int J Orofacial Myology; 2002 Nov; 28():39-48. PubMed ID: 12572259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Speech rate effects upon intelligibility and acceptability of dysarthric speech.
    Dagenais PA; Brown GR; Moore RE
    Clin Linguist Phon; 2006; 20(2-3):141-8. PubMed ID: 16428230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Be Clear: A New Intensive Speech Treatment for Adults With Nonprogressive Dysarthria.
    Park S; Theodoros D; Finch E; Cardell E
    Am J Speech Lang Pathol; 2016 Feb; 25(1):97-110. PubMed ID: 26882004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Speech rate treatments for individuals with dysarthria: a tutorial.
    Blanchet PG; Snyder GJ
    Percept Mot Skills; 2010 Jun; 110(3 Pt 1):965-82. PubMed ID: 20681347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of smooth speech on the speech production of an individual with ataxic dysarthria.
    Stocks R; Dacakis G; Phyland D; Rose M
    Brain Inj; 2009 Sep; 23(10):820-9. PubMed ID: 19697171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ataxic dysarthria: treatment sequences based on intelligibility and prosodic considerations.
    Yorkston KM; Beukelman DR
    J Speech Hear Disord; 1981 Nov; 46(4):398-404. PubMed ID: 7300267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinematic correlates of speaking rate changes in stuttering and normally fluent adults.
    Smith A; Kleinow J
    J Speech Lang Hear Res; 2000 Apr; 43(2):521-36. PubMed ID: 10757701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Articulatory movements during vowels in speakers with dysarthria and healthy controls.
    Yunusova Y; Weismer G; Westbury JR; Lindstrom MJ
    J Speech Lang Hear Res; 2008 Jun; 51(3):596-611. PubMed ID: 18506038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of speaker and listener variables on intelligibility of dysarthric speech.
    Patel R; Usher N; Kember H; Russell S; Laures-Gore J
    J Commun Disord; 2014; 51():13-8. PubMed ID: 25113966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sentence-Level Movements in Parkinson's Disease: Loud, Clear, and Slow Speech.
    Kearney E; Giles R; Haworth B; Faloutsos P; Baljko M; Yunusova Y
    J Speech Lang Hear Res; 2017 Dec; 60(12):3426-3440. PubMed ID: 29209727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Construct-related validity of the TOCS measures: comparison of intelligibility and speaking rate scores in children with and without speech disorders.
    Hodge MM; Gotzke CL
    J Commun Disord; 2014; 51():51-63. PubMed ID: 25069811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Auditory vs visual speech timing cues as external rate control to enhance verbal intelligibility in mixed spastic-ataxic dysarthric speakers: a pilot study.
    Pilon MA; McIntosh KW; Thaut MH
    Brain Inj; 1998 Sep; 12(9):793-803. PubMed ID: 9755370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Speech Prosody Across Stimulus Types for Individuals with Parkinson's Disease.
    K-Y Ma J; Schneider CB; Hoffmann R; Storch A
    J Parkinsons Dis; 2015; 5(2):291-9. PubMed ID: 25697957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term treatment of severe dysarthria: a case study.
    Simpson MB; Till JA; Goff AM
    J Speech Hear Disord; 1988 Nov; 53(4):433-40. PubMed ID: 2972886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of rate reduction and increased loudness on acoustic measures of anticipatory coarticulation in multiple sclerosis and Parkinson's disease.
    Tjaden K; Wilding GE
    J Speech Lang Hear Res; 2005 Apr; 48(2):261-77. PubMed ID: 15989391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intensive treatment of dysarthria secondary to stroke.
    Mahler LA; Ramig LO
    Clin Linguist Phon; 2012 Aug; 26(8):681-94. PubMed ID: 22774928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Speech-like and non-speech lip kinematics and coordination in aphasia.
    Bose A; van Lieshout P
    Int J Lang Commun Disord; 2012; 47(6):654-72. PubMed ID: 23121525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.